@ERSpublicationsIn obese children with obstructive sleep apnoea insulin resistance is common while lipids do not show a clear pattern http://ow.ly/XNR9sIn adults, obstructive sleep apnoea (OSA) is often associated with metabolic alterations. Although obesity is a major culprit [1], large epidemiological studies have reported a metabolic risk associated with OSA that is independent of obesity. In particular, meta-analyses have shown that effective treatment of OSA by continuous positive airway pressure (CPAP) improves glycaemic control in both diabetic [2] and nondiabetic patients [3].Intermittent hypoxia is an important mechanism by which OSA affects metabolism, as supported by experimental observations showing that intermittent hypoxia negatively interferes with both glucose and lipid metabolism [4,5]. Altered sleep structure, as often found in OSA, may also play an important role. In adult humans, experimental sleep fragmentation [6] and deprivation of slow wave sleep (SWS) [7] decreased insulin sensitivity. In healthy adolescents, two studies found that insulin sensitivity was negatively correlated to stage 1 non-rapid eye movement (non-REM) sleep, and positively to SWS duration [8,9]. Furthermore, in another population of healthy adolescents, partial sleep deprivation, with preserved SWS and a reduced amount of REM sleep, was followed by an increase in insulin resistance [10]. A correlation between short sleep duration and insulin resistance has also been found with actigraphic studies both in adolescents [11,12] and in younger children [13].Paediatric OSA shows major differences compared with the adult disease [14]. First, the number of respiratory events and the degree of nocturnal hypoxaemia are usually lower in children than in adults. Second, sleep duration is physiologically longer in children than in adults and respiratory events, although possibly causing some sleep fragmentation, are associated with a sleep structure that appears to be better preserved than in adults. Third, duration of disease and exposure to additional risk factors for several complications is limited in children, as opposed to the decades of exposure to sleep disordered breathing (SDB) and risk factors typical of adult patients. Therefore, differences between adults and children with OSA could explain a different impact on metabolism. The picture is even more complex if we consider that paediatric disease has two main phenotypes: one typical of lean children with adenotonsillar hypertrophy, which usually occurs at a younger age and has a similar prevalence in both sexes; and one typical of obese children that is more similar to adult OSA and usually appears in adolescence, more often in males [15]. Onset of puberty is an additional factor known to affect metabolism in children, increasing insulin resistance at least in males [16]. The impact of all these variables, and the small sample size of several paediatric studies, probably contribute to the difficulties in clear interpretation of the apparently conflicting data available i...